Coherus Oncology (CHRS) Gross Margin (2019 - 2026)
Coherus Oncology (CHRS) reported Gross Margin of 70.35% for Q2 2026, up 3.46 percentage points from 66.89% a year earlier and up 1.33 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Gross Margin (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Coherus Oncology's Gross Margin came in at 68.94%, up 5.37 percentage points year-over-year; for FY2025, it came in at 67.24%, up 0.31 percentage points from FY2024.
- Gross Margin has a five-year change of -24.84 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 66.93% in FY2024 (+28.74 pp), 38.19% in FY2023 (-28.60 pp), 66.79% in FY2022 (-15.57 pp) and 82.36% in FY2021 (-9.72 pp).
- The Q2 2026 figure ranks as the highest quarterly Gross Margin since Q2 2024.
- Year over year, Gross Margin has now increased in each of the last four quarters, with an average year-over-year change of +11.46 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was Q4 2024 (a gain of 56.84 percentage points); the low point was Q4 2023 (a drop of 61.08 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 69.02% (Q1 2026), 68.27% (Q4 2025) and 67.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 72.78% |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 70.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.35% |
| Mar 31, 2026 | 69.02% |
| Dec 31, 2025 | 68.27% |
| Sep 30, 2025 | 67.84% |
| Jun 30, 2025 | 66.89% |
| Mar 31, 2025 | 65.09% |
| Dec 31, 2024 | 64.44% |
| Sep 30, 2024 | 54.91% |
| Jun 30, 2024 | 82.43% |
| Mar 31, 2024 | 37.65% |
| Dec 31, 2023 | 7.60% |
| Sep 30, 2023 | 56.14% |
| Jun 30, 2023 | 57.68% |
| Mar 31, 2023 | 47.98% |
| Dec 31, 2022 | 68.68% |
| Sep 30, 2022 | 22.43% |
| Jun 30, 2022 | 81.25% |
| Mar 31, 2022 | 84.41% |
| Dec 31, 2021 | 83.50% |
| Sep 30, 2021 | 74.21% |
API Access
Coherus Oncology Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();